Roszdravnadzor issued warnings to pharmacies due to the inflated price of a drug for diabetes in Moscow
[ad_1]
Roszdravnadzor issued a warning to 26 pharmacies in the capital because of the sale of Ozempik at an inflated price. The drug is used in the treatment of diabetes. AT press service The departments explained that a similar monitoring of pricing policy in the future will be carried out in all regions of Russia, and not only in Moscow and the Moscow region.
“In the course of monitoring, 26 legal entities were identified whose prices for the Ozempik drug range from 12,000 to 24,000 rubles,” the supervisory authority said about the results of checking the cost of the Danish-made drug. Its maximum retail price should not exceed 7.7 thousand rubles. (in view of VAT).
In total, Roszdravnadzor issued 42 warnings to pharmacies: 20 – on the fact of overpricing Ozempik with a dosage of 1 mg, 22 – with a dose of 0.25 mg.
November 15 RBC published material that about 30 metropolitan pharmacies inflate the price of Ozempik several times. The drug is included in the list of vital and essential.
[ad_2]
Source link
